These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 920366)

  • 1. Hyperreactive arterial endothelial cells in atherogenesis. Effect of smooth muscle relaxants.
    Shimamoto T; Moriya K; Kobayashi DV; Takahashi T; Numano F
    Adv Exp Med Biol; 1977; 82():234-6. PubMed ID: 920366
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible effect of drugs on arterial wall metabolism in experimental atherosclerosis.
    Mrhová O; Urbanová D
    Czech Med; 1982; 5(3):165-75. PubMed ID: 6814877
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperreactive arterial endothelial cells in atherogenesis and cyclic AMP phosphodiesterase inhibitor in prevention and treatment of atherosclerotic disorders.
    Shimamoto T
    Jpn Heart J; 1975 Jan; 16(1):76-97. PubMed ID: 234547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperreactive arterial endothelial cells: a clue for the treatment of atherosclerosis.
    Shimamoto T; Hidaka H; Moriya K; Kobayashi M; Takahashi T; Numano F
    Ann N Y Acad Sci; 1976; 275():266-85. PubMed ID: 188368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phthalazinol (EG 626) and pyridinolcarbamate (Anginin) on lipolytic enzyme activities in rat adipose tissue -in vivo and in vitro-.
    Tomita T; Yonekura I; Shirasaki Y; Hayashi E; Numano F
    Jpn J Pharmacol; 1980 Feb; 30(1):65-73. PubMed ID: 6249948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells.
    Lautier D; Canitrot Y; Salmon JM
    Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of pyridinolcarbamate on lipid metabolism of normal and arteriosclerotic intima in human femoral arteries].
    Horsch AK; Gilli J; Schreiter U
    Verh Dtsch Ges Inn Med; 1974; 80():952-4. PubMed ID: 4454699
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid synthesis in normal and atherosclerotic human intima in vitro under the effect of pyridinolcarbamate].
    Gilli J; Horsch AK; Leyendecker I; Schreiter U
    Vasa; 1976; 5(2):88-94. PubMed ID: 973428
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental animal studies on the anti-inflammatory effect of pyridinolcarbamate].
    Rave O; Wagner H; Hrubesch M; Junge-Hülsing G; Hauss WH
    Arzneimittelforschung; 1974 Nov; 24(11):1779-85. PubMed ID: 4280911
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].
    Szondy E; Horváth M; Füst G; Fehér J; Link E; Gerö S
    Orv Hetil; 1979 Jun; 120(23):1391-2. PubMed ID: 492681
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proceedings: Effect of pyridinolcarbamate on the lipid metabolism of normal and atherosclerotic intima in human femoral arteries].
    Horsch AK; Gilli J; Schreiter U
    MMW Munch Med Wochenschr; 1974 May; 116(22):1112. PubMed ID: 4211589
    [No Abstract]   [Full Text] [Related]  

  • 12. Biopharmaceutical studies on pyridinolcarbamate. V. Effect of repeated administration of pyridinolcarbamate on the renal excretion of sulbenicillin in rabbits.
    Suenaga A; Nakagawa H; Huang MT; Imamura Y; Otagiri M; Ichibagase H
    Acta Pharm Suec; 1985; 22(1):45-52. PubMed ID: 4024967
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic lathyrism and pyridinol carbamate. Study of aorta and plasma during long term intoxication.
    Julian M; De Graeve J; Pieraggi MT; Thiers JC; Bouissou H
    Pharmacol Res Commun; 1980 Oct; 12(9):847-54. PubMed ID: 7443765
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthetic studies of antiatherogenic agents. (VI) Syntheses of carbamate derivative of substituted phthalazinones (author's transl)].
    Eguchi Y; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1977; 11():49-53. PubMed ID: 284539
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of repeated administration of pyridinolcarbamate on hypoglycemic activity after oral administration of acetohexamide in rabbits.
    Suenaga A
    Pharm Acta Helv; 1986; 61(4):125-8. PubMed ID: 3725809
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction between salicylic acid and repeatedly administered pyridinolcarbamate in rabbits.
    Suenaga A; Kinoshita Y; Imamura Y; Otagiri M; Ichibagase H
    Pharm Acta Helv; 1987; 62(8):221-5. PubMed ID: 3659058
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of pyridinolcarbamate (PDC) on surface microvessels in man: preliminary findings.
    Rouen LR; Terry EN; Clauss RH; Redisch W
    Bibl Anat; 1975; 13():358-9. PubMed ID: 1231780
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of effect of phenformin, pyridinolcarbamate combined with a decalcifying agent, and an onion--garlic mixture on growth and necrosis of aortic atherosclerosis in ballooned swine.
    Lee WM; Lee KT
    Exp Mol Pathol; 1980 Dec; 33(3):345-8. PubMed ID: 6450054
    [No Abstract]   [Full Text] [Related]  

  • 19. Atherosclerosis-inhibiting effect of an antibradykinin agent, pyridinolcarbamate.
    Shimamoto T; Numano F; Fujita T
    Am Heart J; 1966 Feb; 71(2):216-27. PubMed ID: 5902101
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of pyridinolcarbamate on enzyme changes in the arterial wall of rats intoxicated with allylamine.
    Mrhová O; Shimamoto T; Numano F
    Biochem Pharmacol; 1975 Mar; 24(5):567-70. PubMed ID: 1125060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.